参考文献/References:
[1]中国人民共和国国家卫生和计划生育委员会.临床实验室对商品定量试剂盒分析性能的验证(WS/T420-2013)[S].2013.
[2]National Committee for Clinical Labomtory Standards.EP9-A2 method comparison and bais estimation using patient samples[S].Wayne,PA.USA:NCCLS,2002.
[3]国家食品药品监督管理局.胱抑素C测定试剂(盒)(YY/T1230-2014)[S].2014.
[4]张秀明.浅析定量检验程序分析性能验证实验方案设计[J].中华检验医学杂志,2015(6):428-430.
[5]罗立梅,张彬,陈刚.化学发光微粒子免疫分析法检测性激素6项的性能验证[J].国际检验医学杂志,2017,38(9):1214-1216,1219.
[6]刘海燕,李伟娜,肖波,等.胱抑素C临床检验及在肾脏疾病应用中的研究进展[J].河北医药,2015(21):3311-3315.
[7]周恩武,李明,刘跃平,等.血清胱抑素C测定的临床意义及方法学研究进展[J].现代中西医结合杂志,2014(12):1367-1368.
[8]张小燕,杨宇.胱抑素C的临床应用及检测标准化进展[J].标记免疫分析与临床,2017,24(6):717-720.
相似文献/References:
[1]李 艳.胱抑素C临床检验及对诊断肾脏疾病的临床价值[J].医学信息,2018,31(04):42.[doi:10.3969/j.issn.1006-1959.2018.04.014]
LI Yan.Clinical Test of Cystatin C and its Clinical Value in the Diagnosis of Renal Diseases[J].Journal of Medical Information,2018,31(15):42.[doi:10.3969/j.issn.1006-1959.2018.04.014]
[2]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(15):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[3]黄晓楠,刘玉林.全自动化学发光分析仪检测孕酮和人绒毛膜促性腺激素的性能验证[J].医学信息,2022,35(11):134.[doi:10.3969/j.issn.1006-1959.2022.11.035]
HUANG Xiao-nan,LIU Yu-lin.Performance verification of Automatic Chemiluminescence Analyzer for Detection of Progesterone and Human Chorionic Gonadotropin[J].Journal of Medical Information,2022,35(15):134.[doi:10.3969/j.issn.1006-1959.2022.11.035]
[4]叶 亮,李运泽,彭继承,等.血清Cys-C、α1-MG联合检测在早期肝肾综合征诊断中的意义[J].医学信息,2022,35(16):67.[doi:10.3969/j.issn.1006-1959.2022.16.014]
YE Liang,LI Yun-ze,PENG Ji-cheng,et al.Significance of Combined Detection of Serum Cys-C and α1-MG in Diagnosis of Early Hepatorenal Syndrome[J].Journal of Medical Information,2022,35(15):67.[doi:10.3969/j.issn.1006-1959.2022.16.014]
[5]韩佳妮.参芪地黄汤治疗早期糖尿病肾病的疗效[J].医学信息,2019,32(22):139.[doi:10.3969/j.issn.1006-1959.2019.22.047]
HAN Jia-ni.Effect of Shenqi Dihuang Decoction in Treating Early Diabetic Nephropathy[J].Journal of Medical Information,2019,32(15):139.[doi:10.3969/j.issn.1006-1959.2019.22.047]
[6]伊学军,翟建新.胱抑素C检测及其在肾脏相关疾病中的应用[J].医学信息,2020,33(04):55.[doi:10.3969/j.issn.1006-1959.2020.04.017]
YI Xue-jun,ZHAI Jian-xin.Cystatin C Detection and its Application in Kidney-related Diseases[J].Journal of Medical Information,2020,33(15):55.[doi:10.3969/j.issn.1006-1959.2020.04.017]
[7]段宗宝,肖三法,罗惠群.环磷酰胺联合氢氯噻嗪治疗2型糖尿病肾病的临床研究[J].医学信息,2021,34(23):159.[doi:10.3969/j.issn.1006-1959.2021.23.048]
DUAN Zong-bao,XIAO San-fa,LUO Hui-qun.Clinical Study of Cyclophosphamide Combined with Hydrochlorothiazide in the Treatment of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2021,34(15):159.[doi:10.3969/j.issn.1006-1959.2021.23.048]
[8]马 燕,王晓忠,延国威,等.乙肝肝硬化低血钠症患者血清钠、肌酐以及胱抑素C与肾功能损害程度的关系[J].医学信息,2020,33(19):55.[doi:10.3969/j.issn.1006-1959.2020.19.017]
MA Yan,WANG Xiao-zhong,YAN Guo-wei,et al.The Relationship Between Serum Sodium,Creatinine,Cystatin C and the Degree of Renal Damage in Patients with Hepatitis B Liver Cirrhosis and Hyponatremia[J].Journal of Medical Information,2020,33(15):55.[doi:10.3969/j.issn.1006-1959.2020.19.017]
[9]舒霁坤,沈学耕.慢性心力衰竭患者炎症细胞因子水平与心室重构的相关性分析[J].医学信息,2022,35(02):100.[doi:10.3969/j.issn.1006-1959.2022.02.024]
SHU Ji-kun,SHEN Xue-geng.Correlation Between Inflammatory Cytokines and Ventricular Remodelingin Patients with Chronic Heart Failure[J].Journal of Medical Information,2022,35(15):100.[doi:10.3969/j.issn.1006-1959.2022.02.024]
[10]张慧敏,夏海龙,刘 北,等.胱抑素C、铁蛋白与骨髓瘤骨病病情严重程度及预后的关系[J].医学信息,2024,37(03):89.[doi:10.3969/j.issn.1006-1959.2024.03.017]
ZHANG Hui-min,XIA Hai-long,LIU Bei,et al.Relationship Between Cystatin C, Ferritin and the Severity, Prognosis of Multiple Myeloma Bone Disease[J].Journal of Medical Information,2024,37(15):89.[doi:10.3969/j.issn.1006-1959.2024.03.017]